STING1 and neoplasm: DNA produced by tumor cells after radiotherapy promotes the anti-tumor effect of radiotherapy by triggering the cGAS/STING pathway to enhance T cell responses in mice to induce anticancer immunity in a STINE-dependent manner [30].